BioSpace News Archive

The study was carried out by Dr. Massimo Nabissi from the School of Pharmacy Section of Experimental Medicine, University of Camerino in Camerino, Italy.

Sirius Medical is pleased to announce that Ascension St. Vincent Carmel and Ascension St. Vincent Evansville are the first U.S. hospitals to implement the Pintuition System in their breast surgery programs.

IVERIC bio, Inc. reported that on June 1, 2022, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive employees.

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced that Janux management will present at the 2022 Jefferies Global Healthcare Conference on Friday, June 10, 2022 at 11:00 a.m. ET in New York.

Arsenal Biosciences, Inc., a privately held programmable cell therapy company engineering advanced CAR T therapies for solid tumors, today announced that the company’s Chief Executive Officer, Ken Drazan, MD, will present in person at the 2022 Jefferies Healthcare Conference on Thursday, June 9 at 4:00 p.m. Eastern time.

Anji Pharma , an emerging global medicines company, today announced the formation of a clinical advisory board to support its lead program, ANJ900, a delayed-release formulation of metformin.

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that management is scheduled to present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 8:00 AM EDT.

Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, announced the appointment of Amin Kamel, Ph.D., as Vice President, DMPK.

Today, at the ENCALS Conference (European Network to Cure ALS) Neuvivo presented an abstract titled: “Plasma biomarkers of microbial translocation are modulated in ALS patients clinically responsive to NP001".